Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy-Reference-Cited by-同舟云学术

Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy

Published:2016-02-03 Issue:10 Volume:7 Page:11223-11237
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Asano Takuya¹²,Hirohashi Yoshihiko¹,Torigoe Toshihiko¹,Mariya Tasuku¹²,Horibe Ryota¹³,Kuroda Takafumi¹²,Tabuchi Yuta¹²,Saijo Hiroshi¹³,Yasuda Kazuyo¹,Mizuuchi Masahito¹²,Takahashi Akari¹,Asanuma Hiroko⁴,Hasegawa Tadashi⁴,Saito Tsuyoshi²,Sato Noriyuki¹

Affiliation:

1. Departments of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan

2. Obsterics and Gynecology, Sapporo Medical University School of Medicine, Sapporo, Japan

3. Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, Japan

4. Surgical Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Cervical Cancer Stem Cells by Phytochemicals;Current Medicinal Chemistry;2024-10

2. Atractyloside inhibits gefitinib‑resistant non‑small‑cell lung cancer cell proliferation;Oncology Letters;2024-07-30

3. mRNA-lncRNA gene expression signature in HPV-associated neoplasia and cervical cancer;Vavilov Journal of Genetics and Breeding;2024-05-30

4. Cancer stem cells: The important role of CD markers, Signaling pathways, and MicroRNAs;Pathology - Research and Practice;2024-04

5. Exploring olfactory receptor family 7 subfamily C member 1 as a novel oral cancer stem cell target for immunotherapy;Cancer Science;2023-06-21